We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
-$150M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Communication Services 3.18%
2 Healthcare 3.02%
3 Financials 2.03%
4 Technology 1.9%
5 Consumer Discretionary 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALIT icon
1126
PUT
Alight
ALIT
$501M
-5,000
Closed -$985K
ALL icon
1127
CALL
Allstate
ALL
$68B
-58,700
Closed -$10.2M
AMCX icon
1128
PUT
AMC Global Media
AMCX
$484M
-20,000
Closed -$243K
AMLX icon
1129
CALL
Amylyx Pharmaceuticals
AMLX
$2.2B
-522,800
Closed -$1.48M
AMT icon
1130
CALL
American Tower
AMT
$80.8B
-12,600
Closed -$2.49M
AMT icon
1131
American Tower
AMT
$80.8B
-13,800
Closed -$2.73M
APGE icon
1132
CALL
Apogee Therapeutics
APGE
$10.1B
-50,000
Closed -$3.32M
APO icon
1133
Apollo Global Management
APO
$73.8B
-15,200
Closed -$1.72M
AR icon
1134
PUT
Antero Resources
AR
$11.1B
-35,000
Closed -$1.01M
ARCB icon
1135
ArcBest
ARCB
$3.13B
-300
Closed -$42.8K
ARCB icon
1136
PUT
ArcBest
ARCB
$3.13B
-12,500
Closed -$1.78M
ARES icon
1137
CALL
Ares Management
ARES
$30.4B
-21,000
Closed -$2.79M
ARM icon
1138
CALL
Arm
ARM
$252B
-212,800
Closed -$26.6M
ARM icon
1139
PUT
Arm
ARM
$252B
-139,600
Closed -$17.4M
ARMK icon
1140
Aramark
ARMK
$15B
-2,200
Closed -$71.5K
ARMK icon
1141
PUT
Aramark
ARMK
$15B
-75,000
Closed -$2.44M
ARQT icon
1142
Arcutis Biotherapeutics
ARQT
$3.26B
-79,500
Closed -$719K
ASPN icon
1143
Aspen Aerogels
ASPN
$388M
-80,048
Closed -$1.88M
ATKR icon
1144
CALL
Atkore
ATKR
$3.16B
-24,000
Closed -$4.57M
ATKR icon
1145
PUT
Atkore
ATKR
$3.16B
-24,000
Closed -$4.57M
ATXS
1146
CALL
DELISTED
Astria Therapeutics
ATXS
-976,300
Closed -$13.7M
ATXS
1147
DELISTED
Astria Therapeutics
ATXS
-300,000
Closed -$4.22M
ATXS
1148
PUT
DELISTED
Astria Therapeutics
ATXS
-22,500
Closed -$317K
AUTL
1149
Autolus Therapeutics
AUTL
$495M
-20,100
Closed -$128K
AXSM icon
1150
CALL
Axsome Therapeutics
AXSM
$10.7B
-38,500
Closed -$3.07M

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Communication Services at 3.2% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Financials.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.